NewGenIvf Group Limited NIVF NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Plans • TH • USD

SharesGrow Score

48/100

2/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

NewGenIvf Group Limited (NIVF) trades at a trailing P/E of 0.1, forward P/E of 0.5. Trailing earnings yield is 720.49%, forward earnings yield 200.00%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $124.37.

Criteria proven by this page:

VALUE (100/100, Pass) — P/E is below market average (0.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (720.49%).
PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Trailing Earnings Yield 720.49% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

48/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

Proven by this page

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

36/100

→ Income

✓

GROWTH

90/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — NIVF

Valuation Multiples

P/E (TTM)0.1

Forward P/E0.5

PEG Ratio0.01

Forward PEG0.01

P/B Ratio0.05

P/S Ratio0.45

EV/EBITDA0.6

Per Share Data

EPS (TTM)$15.56

Forward EPS (Est.)$4.74

Book Value / Share$44.18

Revenue / Share$4.60

FCF / Share$-10.81

Yields & Fair Value

Earnings Yield720.49%

Forward Earnings Yield200.00%

Dividend Yield0.00%

Graham Number$124.37

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2021	-58,026,129.0	0.00	-39,858.76	7,510.42	-
2022	69,968.1	-0.05	469.72	5,399.07	-
2023	263,412.4	-3,288.20	9,180.41	6,677.27	-
2024	-5,445.4	19.49	-2,726.29	526.20	-
2025	0.0	0.00	0.00	0.00	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2021	$0.00	$4.12M	$-533.00	-0%
2022	$0.90	$5.94M	$458.67K	7.7%
2023	$-0.13	$5.14M	$-691K	-13.5%
2024	$-4.61	$5.43M	$-525K	-9.7%

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$4.74	$4.74 – $4.74	$65.1M	$65.1M – $65.1M	1
2027	$9.34	$9.34 – $9.34	$180.4M	$180.4M – $180.4M	1
2028	$14.70	$14.70 – $14.70	$270.6M	$270.6M – $270.6M	1